The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

GSK PLC closed 22.73% below its 52-week high of £18.24, which the company reached on May 16th.

NET PROFIT FORECAST: Net profit is expected to rise to 1.67 billion pounds from 1.05 billion pounds, according to a consensus provided by the company. London-listed shares in GSK are up 4.1% since the ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...